Publications

2004
231. Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents.
Schweinitz A, Steinmetzer T, Banke IJ, Arlt MJ, Stürzebecher A, Schuster O, Geissler A, Giersiefen H, Zeslawska E, Jacob U, Krüger A, Stürzebecher J
J Biol Chem. 2004 Aug 6.
PMID: 15150279 [PubMed - in process]
232. Gene delivery to respiratory epithelial cells by magnetofection.
Gersting SW, Schillinger U, Lausier J, Nicklaus P, Rudolph C, Plank C, Reinhardt D, Rosenecker J
J Gene Med. 2004 Aug .
PMID: 15293350 [PubMed - in process]
233. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer.
Huth S, Lausier J, Gersting SW, Rudolph C, Plank C, Welsch U, Rosenecker J
J Gene Med. 2004 Aug .
PMID: 15293351 [PubMed - in process]
234. Genuine DNA/polyethylenimine (PEI) complexes improve transfection properties and cell survival.
Erbacher P, Bettinger T, Brion E, Coll JL, Plank C, Behr JP, Remy JS
J Drug Target. 2004 May .
PMID: 15506171 [PubMed - in process]
235. Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells.
Anton M, Wagner B, Haubner R, Bodenstein C, Essien BE, Bönisch H, Schwaiger M, Gansbacher B, Weber WA
J Gene Med. 2004 Jan .
PMID: 14716684 [PubMed - in process]
2003
236. Urokinase-type plasminogen activator (uPA) and its receptor (uPAR): development of antagonists of uPA/uPAR interaction and their effects in vitro and in vivo.
Reuning U, Sperl S, Kopitz C, Kessler H, Krüger A, Schmitt M, Magdolen V
Curr Pharm Des. 2003 .
PMID: 12871066 [PubMed - in process]
237. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent.
Mempel M, Voelcker V, Köllisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli AK, Ring J, Abeck D, Ollert M
J Invest Dermatol. 2003 Dec .
PMID: 14675188 [PubMed - in process]
238. Increase of anti-metastatic efficacy by selectivity- but not affinity-optimization of synthetic serine protease inhibitors.
Banke IJ, Arlt MJ, Pennington C, Kopitz C, Steinmetzer T, Schweinitz A, Gansbacher B, Quigley JP, Edwards DR, Stürzebecher J, Krüger A
Biol Chem. .
PMID: 14669995 [PubMed - in process]
239. Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer.
Bengel FM, Anton M, Richter T, Simoes MV, Haubner R, Henke J, Erhardt W, Reder S, Lehner T, Brandau W, Boekstegers P, Nekolla SG, Gansbacher B, Schwaiger M
Circulation. 2003 Oct 28.
PMID: 14530205 [PubMed - in process]
240. A novel transfecting peptide comprising a tetrameric nuclear localization sequence.
Ritter W, Plank C, Lausier J, Rudolph C, Zink D, Reinhardt D, Rosenecker J
J Mol Med (Berl). 2003 Nov .
PMID: 14574456 [PubMed - in process]